-
1
-
-
0021207214
-
A classification of antiarrhythmic actions reassessed after a decade of new drugs
-
Vaughan Williams E.M. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol. 24:1984;129-147.
-
(1984)
J Clin Pharmacol
, vol.24
, pp. 129-147
-
-
Vaughan Williams, E.M.1
-
2
-
-
0025676658
-
Channel specificity in antiarrhythmic drug action: Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias
-
Colatsky T.J., Follmer C.H., Starmer C.F. Channel specificity in antiarrhythmic drug action: mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation. 92:1990;2235-2242.
-
(1990)
Circulation
, vol.92
, pp. 2235-2242
-
-
Colatsky, T.J.1
Follmer, C.H.2
Starmer, C.F.3
-
3
-
-
0027485907
-
Arrhythmia control by prolongating repolarization: The concept and its potential therapeutic impact
-
Singh B.N. Arrhythmia control by prolongating repolarization: the concept and its potential therapeutic impact. Eur Heart J. 14(suppl H.):1993;14-23.
-
(1993)
Eur Heart J
, vol.14
, Issue.SUPPL. H.
, pp. 14-23
-
-
Singh, B.N.1
-
4
-
-
0026050195
-
A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms
-
The Sicilian Gambit. Task Force of the Working Group on arrhythmias of the European Society of Cardiology
-
The Sicilian Gambit. Task Force of the Working Group on arrhythmias of the European Society of Cardiology. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991, 84: 1831-51.
-
(1991)
Circulation
, vol.84
, pp. 1831-1851
-
-
-
5
-
-
0027371046
-
New class III antiarrhythmic drugs
-
Katristis D., Camm A.J. New class III antiarrhythmic drugs. Eur Heart J. 14(suppl H):1993;93-99.
-
(1993)
Eur Heart J
, vol.14
, Issue.SUPPL. H
, pp. 93-99
-
-
Katristis, D.1
Camm, A.J.2
-
7
-
-
0029057635
-
Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells
-
Mori K., Hara Y., Saito T., Masuda Y., Nakaya H. Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Circulation. 91:1995;2834-2843.
-
(1995)
Circulation
, vol.91
, pp. 2834-2843
-
-
Mori, K.1
Hara, Y.2
Saito, T.3
Masuda, Y.4
Nakaya, H.5
-
8
-
-
0024321898
-
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
-
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989, 321: 406-412.
-
(1989)
N Engl J Med
, vol.321
, pp. 406-412
-
-
-
9
-
-
0023158384
-
Amiodarone
-
Mason J.W. Amiodarone. N Engl J Med. 316:1987;455-465.
-
(1987)
N Engl J Med
, vol.316
, pp. 455-465
-
-
Mason, J.W.1
-
11
-
-
0030025539
-
Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias
-
Levine J.M., Massumi A., Scheinman M.S.et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol. 27:1996;67-75.
-
(1996)
J Am Coll Cardiol
, vol.27
, pp. 67-75
-
-
Levine, J.M.1
Massumi, A.2
Scheinman, M.S.3
-
12
-
-
0027201134
-
The CASCADE investigators randomized antiarrhythmic drug therapy in survivors of cardiac arrest (CASCADE study)
-
The CASCADE investigators randomized antiarrhythmic drug therapy in survivors of cardiac arrest (CASCADE study). Am J Cardiol 1993, 72: 280-287.
-
(1993)
Am J Cardiol
, vol.72
, pp. 280-287
-
-
-
13
-
-
0025688313
-
Effects of antiarrhythmic on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)
-
Burkart F., Pfisterer M., Kiowski W., Follath F., Burckhardt D. Effects of antiarrhythmic on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol. 16:1990;1711-1718.
-
(1990)
J Am Coll Cardiol
, vol.16
, pp. 1711-1718
-
-
Burkart, F.1
Pfisterer, M.2
Kiowski, W.3
Follath, F.4
Burckhardt, D.5
-
14
-
-
0026497728
-
Effects of amiodarone on mortality after myocardial infarction: A double bind, placebo-controlled, pilot study
-
Ceremuzynski F., Kleczar E., Kreminska-Pakula M.et al. Effects of amiodarone on mortality after myocardial infarction: a double bind, placebo-controlled, pilot study. J Am Coll Cardiol. 20:1992;1051-1062.
-
(1992)
J Am Coll Cardiol
, vol.20
, pp. 1051-1062
-
-
Ceremuzynski, F.1
Kleczar, E.2
Kreminska-Pakula, M.3
-
15
-
-
0031029373
-
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT
-
Cairns J.A., Connolly S.J., Roberts R., Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet. 349:1997;675-682.
-
(1997)
Lancet
, vol.349
, pp. 675-682
-
-
Cairns, J.A.1
Connolly, S.J.2
Roberts, R.3
Gent, M.4
-
16
-
-
0031038213
-
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
-
Julian D.G., Camm A.J., Frangin G., Janse M.J., Munoz A., Schwartz P.J., Simon P. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet. 349:1997;667-674.
-
(1997)
Lancet
, vol.349
, pp. 667-674
-
-
Julian, D.G.1
Camm, A.J.2
Frangin, G.3
Janse, M.J.4
Munoz, A.5
Schwartz, P.J.6
Simon, P.7
-
17
-
-
0027998462
-
Randomized trial of low-dose amiodarone in patients with severe congestive heart failure
-
Doval H.C., Nul D.R., Grancelli H.O., Perrone S.V., Bortman G.R., Curiel L. Randomized trial of low-dose amiodarone in patients with severe congestive heart failure. Lancet. 344:1994;493-498.
-
(1994)
Lancet
, vol.344
, pp. 493-498
-
-
Doval, H.C.1
Nul, D.R.2
Grancelli, H.O.3
Perrone, S.V.4
Bortman, G.R.5
Curiel, L.6
-
18
-
-
0029004921
-
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias
-
Singh S.N., Fletcher R.D., GrossFisher S.et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. N Engl J Med. 333:1995;77-82.
-
(1995)
N Engl J Med
, vol.333
, pp. 77-82
-
-
Singh, S.N.1
Fletcher, R.D.2
Grossfisher, S.3
-
19
-
-
0030958383
-
Heart rate is a marker of amiodarone mortality reduction in severe heart failure
-
Nul D.R., Doval H.C., Grancelli H.O.et al. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. J Am Coll Cardiol. 29:1997;1199-1205.
-
(1997)
J Am Coll Cardiol
, vol.29
, pp. 1199-1205
-
-
Nul, D.R.1
Doval, H.C.2
Grancelli, H.O.3
-
21
-
-
0027296250
-
Clinical safety profile of sotalol in the treatment of arrhythmias
-
MacNeil D.J., Davies R.O., Deitchman D. Clinical safety profile of sotalol in the treatment of arrhythmias. Am J Cardiol. 72:1993;44A-50A.
-
(1993)
Am J Cardiol
, vol.72
-
-
MacNeil, D.J.1
Davies, R.O.2
Deitchman, D.3
-
23
-
-
0027179547
-
For the Electrophysiologic study versus electrocardiographic monitoring (ESVEM) investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias
-
Mason J.W. for the Electrophysiologic study versus electrocardiographic monitoring (ESVEM) investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med. 329:1993;445-451.
-
(1993)
N Engl J Med
, vol.329
, pp. 445-451
-
-
Mason, J.W.1
-
24
-
-
0029560485
-
Long-term efficacy of D,L-sotalol in patients with sustained ventricular tachycardia refractory to class I. antiarrhythmic drugs
-
Kühlkamp V., Mermi J., Mewis C., Braun U., Seipel L. Long-term efficacy of D,L-sotalol in patients with sustained ventricular tachycardia refractory to class I. antiarrhythmic drugs. Eur Heart J. 16:1995;1625-1631.
-
(1995)
Eur Heart J
, vol.16
, pp. 1625-1631
-
-
Kühlkamp, V.1
Mermi, J.2
Mewis, C.3
Braun, U.4
Seipel, L.5
-
25
-
-
0029619196
-
Effects of the new class III dofetilide on the atrial and ventricular intracardiac monophasic action potential in patients with angina pectoris
-
Sedgwick M.L., Dalrymple I., Rae A.P., Cobbe S.M. Effects of the new class III dofetilide on the atrial and ventricular intracardiac monophasic action potential in patients with angina pectoris. Eur Heart J. 16:1995;1641-1646.
-
(1995)
Eur Heart J
, vol.16
, pp. 1641-1646
-
-
Sedgwick, M.L.1
Dalrymple, I.2
Rae, A.P.3
Cobbe, S.M.4
-
26
-
-
0029063772
-
r blockade: Implications for the antifibrillatory efficacy of potassium channel blocking agents
-
r blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents. J Am Coll Cardiol. 25:1995;1609-1614.
-
(1995)
J Am Coll Cardiol
, vol.25
, pp. 1609-1614
-
-
Vanoli, E.1
Priori, S.2
Nakagawa, H.3
Hirao, K.4
Napolitano, C.5
Diehl, L.6
Lazzara, R.7
Schwartz, P.J.8
-
27
-
-
0029002142
-
Survival with oral D-sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design and methods (the SWORD trial)
-
Waldo A.l., Camm A.J., deRuyter H.et al. Survival with oral D-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design and methods (the SWORD trial). Am J Cardiol. 75:1995;1023-1027.
-
(1995)
Am J Cardiol
, vol.75
, pp. 1023-1027
-
-
Waldo, A.L.1
Camm, A.J.2
Deruyter, H.3
-
28
-
-
0028020043
-
A trial flutter can be terminated by a class III antiarrhythmic drug but not by class Ic drug
-
Crijns H.J., WanGelder I.C., Kingma J.H., Dunsenman P.H., Gosselink A.T.M., Lie K.I. A trial flutter can be terminated by a class III antiarrhythmic drug but not by class Ic drug. Eur Heart J. 15:1994;1403-1408.
-
(1994)
Eur Heart J
, vol.15
, pp. 1403-1408
-
-
Crijns, H.J.1
Wangelder, I.C.2
Kingma, J.H.3
Dunsenman, P.H.4
Gosselink, A.T.M.5
Lie, K.I.6
-
29
-
-
0031029739
-
Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter
-
Falk R.H., Pollak A., Singh S.N., Friedrich T. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. J Am Coll Cardiol. 29:1997;385-390.
-
(1997)
J Am Coll Cardiol
, vol.29
, pp. 385-390
-
-
Falk, R.H.1
Pollak, A.2
Singh, S.N.3
Friedrich, T.4
-
30
-
-
0000955544
-
Comparison of intravenously-administered dofetilide-versus amiodarone in the acute termination of atrial fibrillation and flutter
-
Bianconi L., Dinelli M., Pappalardo A., Richiardi E., Castro A., Alboni P., Santini M., Dalrymple H.W., Radula D. Comparison of intravenously-administered dofetilide-versus amiodarone in the acute termination of atrial fibrillation and flutter. Circulation. 92(Suppl I):1995;I-774.
-
(1995)
Circulation
, vol.92
, Issue.SUPPL. I
, pp. 774
-
-
Bianconi, L.1
Dinelli, M.2
Pappalardo, A.3
Richiardi, E.4
Castro, A.5
Alboni, P.6
Santini, M.7
Dalrymple, H.W.8
Radula, D.9
-
31
-
-
0028198795
-
Effect of dofetilide on cardiac repolarization in patients with ventricular tachycardia
-
Yuan S., Wohlfart B., Rasmussen H.S., Olsson S., Blomstrom-Lundqvist C. Effect of dofetilide on cardiac repolarization in patients with ventricular tachycardia. Eur Heart J. 15:1994;514-522.
-
(1994)
Eur Heart J
, vol.15
, pp. 514-522
-
-
Yuan, S.1
Wohlfart, B.2
Rasmussen, H.S.3
Olsson, S.4
Blomstrom-Lundqvist, C.5
-
32
-
-
0028789950
-
Electrophysiologic profile and efficacy of intravenous dofetilide, a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia
-
Bashir Y., Thomsen P.E., Kinema J.H.et al. Electrophysiologic profile and efficacy of intravenous dofetilide, a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Am J Cardiol. 76:1995;1040-1044.
-
(1995)
Am J Cardiol
, vol.76
, pp. 1040-1044
-
-
Bashir, Y.1
Thomsen, P.E.2
Kinema, J.H.3
-
33
-
-
0029819618
-
Diamond antiarrhythmic trials
-
Moller M. Diamond antiarrhythmic trials. Lancet. 348:1996;1597-1598.
-
(1996)
Lancet
, vol.348
, pp. 1597-1598
-
-
Moller, M.1
-
34
-
-
0027178719
-
Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans
-
Sager P.T., Nedemanee K., Antimisiaris M.et al. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans. Circulation. 88:1993;1072-1082.
-
(1993)
Circulation
, vol.88
, pp. 1072-1082
-
-
Sager, P.T.1
Nedemanee, K.2
Antimisiaris, M.3
-
35
-
-
0028880376
-
Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: A class III antiarrhythmic agent without cardiodepressant effects
-
Stambler B.S., Gottlieb S.S., Singh B.N., Ramanathan K.B., Ogilby J.D., Ellenbogen K.E. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects. J Am Coll Cardiol. 26:1995;1679-1684.
-
(1995)
J Am Coll Cardiol
, vol.26
, pp. 1679-1684
-
-
Stambler, B.S.1
Gottlieb, S.S.2
Singh, B.N.3
Ramanathan, K.B.4
Ogilby, J.D.5
Ellenbogen, K.E.6
-
36
-
-
9444256916
-
Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter
-
Ellenbogen K.A., Stambler B.S., Wood M.A.et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter. J Am Coll Cardiol. 28:1996;130-136.
-
(1996)
J Am Coll Cardiol
, vol.28
, pp. 130-136
-
-
Ellenbogen, K.A.1
Stambler, B.S.2
Wood, M.A.3
-
37
-
-
0028116076
-
Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium- blocking agent
-
Bargheer K., Bode F., Klein H.U., Trappe H.J., Franz M.R., Lichtlen P.R. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium- blocking agent. Eur Heart J. 15:1994;1409-1414.
-
(1994)
Eur Heart J
, vol.15
, pp. 1409-1414
-
-
Bargheer, K.1
Bode, F.2
Klein, H.U.3
Trappe, H.J.4
Franz, M.R.5
Lichtlen, P.R.6
-
38
-
-
0028106374
-
Risks and benefits of antiarrhythmic therapy
-
Roden D.M. Risks and benefits of antiarrhythmic therapy. N Engl J Med. 331:1994;785-791.
-
(1994)
N Engl J Med
, vol.331
, pp. 785-791
-
-
Roden, D.M.1
-
39
-
-
0027374024
-
Torsades de pointes with Almokalant a new class III antiarrhythmic drug
-
Wiesfeld A.C.P., Crijns H.J.G., Bergstrand R.H., Almgren O., Hillege B.E., Lie K.I. Torsades de pointes with Almokalant a new class III antiarrhythmic drug. Am Heart J. 126:1993;1008-1011.
-
(1993)
Am Heart J
, vol.126
, pp. 1008-1011
-
-
Wiesfeld, A.C.P.1
Crijns, H.J.G.2
Bergstrand, R.H.3
Almgren, O.4
Hillege, B.E.5
Lie, K.I.6
-
40
-
-
24544448349
-
Modulation of the electrophysiologic effects af ambasilide induced by β-adrenergic stimulation in isolated ventricular myocytes
-
Napolitano C., Diehl L., Schwartz P.L., Priori S.G. Modulation of the electrophysiologic effects af ambasilide induced by β-adrenergic stimulation in isolated ventricular myocytes. J Am Coll Cardiol. 23:1994;444A.
-
(1994)
J Am Coll Cardiol
, vol.23
-
-
Napolitano, C.1
Diehl, L.2
Schwartz, P.L.3
Priori, S.G.4
-
41
-
-
0027178409
-
Electrophysiologic effects of E-4031, a new class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias
-
Isomoto S., Shimizu A., Konoe A.et al. Electrophysiologic effects of E-4031, a new class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias. Am J Cardiol. 71:1993;1464-1467.
-
(1993)
Am J Cardiol
, vol.71
, pp. 1464-1467
-
-
Isomoto, S.1
Shimizu, A.2
Konoe, A.3
-
42
-
-
4243493847
-
Electrocardiographic effects of oral MK-499, a new class III antiarrhythmic agent in patients with coronary disease
-
Singh B.N., Ellenbogen K.A., Zoble R.G.et al. Electrocardiographic effects of oral MK-499, a new class III antiarrhythmic agent in patients with coronary disease. J Am Coll Cardiol. 23:1994;92A.
-
(1994)
J Am Coll Cardiol
, vol.23
-
-
Singh, B.N.1
Ellenbogen, K.A.2
Zoble, R.G.3
-
43
-
-
0028558526
-
Amiodarone - Associated proarrhytmic effect - A review with special reference to torsade de pointes tachycardia
-
Hohnloser S.H., Klingenheben T., Singh B.N. Amiodarone - associated proarrhytmic effect - A review with special reference to torsade de pointes tachycardia. Ann Intern Med. 121:1994;529-535.
-
(1994)
Ann Intern Med
, vol.121
, pp. 529-535
-
-
Hohnloser, S.H.1
Klingenheben, T.2
Singh, B.N.3
-
44
-
-
0028927451
-
Regulation of potassium channels by non-sedating antihistamines
-
Berul C.I., Morad M. Regulation of potassium channels by non-sedating antihistamines. Circulation. 91:1995;2220-2225.
-
(1995)
Circulation
, vol.91
, pp. 2220-2225
-
-
Berul, C.I.1
Morad, M.2
-
45
-
-
0028082351
-
Clinical relevance in the generation of U waves, triggered activity and torsades de pointes
-
Antzelevitch C., Sicouri S. Clinical relevance in the generation of U waves, triggered activity and torsades de pointes. J Am Coll Cardiol. 23:1994;259-277.
-
(1994)
J Am Coll Cardiol
, vol.23
, pp. 259-277
-
-
Antzelevitch, C.1
Sicouri, S.2
-
46
-
-
0025164907
-
Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse-use dependence
-
Hondeghem L.M., Snyders D.J. Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and dangers of reverse-use dependence. Circulation. 81:1990;686-690.
-
(1990)
Circulation
, vol.81
, pp. 686-690
-
-
Hondeghem, L.M.1
Snyders, D.J.2
-
47
-
-
0000955543
-
Frequency-dependent electrophysiologic effects of dofetilide in humans
-
Sager P.T. Frequency-dependent electrophysiologic effects of dofetilide in humans. Circulation. 92(Suppl I):1995;I-774.
-
(1995)
Circulation
, vol.92
, Issue.SUPPL. I
, pp. 774
-
-
Sager, P.T.1
-
48
-
-
0030025856
-
Assessment of reserve-use dependent blocking actions of class III antiarrhythmic drugs by 24-hour holter electrocardiography
-
Okada Y., Ogawa S., Sadanaga T., Mitamura H. Assessment of reserve-use dependent blocking actions of class III antiarrhythmic drugs by 24-hour holter electrocardiography. J Am Coll Cardiol. 27:1996;84-89.
-
(1996)
J Am Coll Cardiol
, vol.27
, pp. 84-89
-
-
Okada, Y.1
Ogawa, S.2
Sadanaga, T.3
Mitamura, H.4
-
51
-
-
0025337633
-
Hemodynamic effect of oral nicorandil in congestive heart failure
-
Tice F.D., Binkley P.F., Cody R.J., Moeschberger M.L., Mohrland J.S., Wolf D.L., Leier C.V. Hemodynamic effect of oral nicorandil in congestive heart failure. Am J Cardiol. 65:1990;1361-1367.
-
(1990)
Am J Cardiol
, vol.65
, pp. 1361-1367
-
-
Tice, F.D.1
Binkley, P.F.2
Cody, R.J.3
Moeschberger, M.L.4
Mohrland, J.S.5
Wolf, D.L.6
Leier, C.V.7
-
52
-
-
0025037862
-
Usefulness of nicorandil in congestive heart failure
-
Galie N., Varani E., Maiello L., Boriani G., Boschi S., Binetti G., Magnani B. Usefulness of nicorandil in congestive heart failure. Am J Cardiol. 65:1990;343-348.
-
(1990)
Am J Cardiol
, vol.65
, pp. 343-348
-
-
Galie, N.1
Varani, E.2
Maiello, L.3
Boriani, G.4
Boschi, S.5
Binetti, G.6
Magnani, B.7
-
53
-
-
0029079155
-
Comparison of hemodynamic effects and plasma cyclic guanosin monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure
-
Tsutamoto T., Kinoshita M., Hisanaga T., Maeda Y., Maeda K., Wada A., Fukai D., Yoshida S. Comparison of hemodynamic effects and plasma cyclic guanosin monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure. Am J Cardiol. 75:1995;1162-1165.
-
(1995)
Am J Cardiol
, vol.75
, pp. 1162-1165
-
-
Tsutamoto, T.1
Kinoshita, M.2
Hisanaga, T.3
Maeda, Y.4
Maeda, K.5
Wada, A.6
Fukai, D.7
Yoshida, S.8
-
54
-
-
0009612437
-
Evaluation of antianginal and antiischemic efficacy of nicorandil: Results of a multicenter study
-
Thadani U., Strauss W., Glasser S.P., Frishman W., Burger A.J., Locker J., Mohrland J.S. Evaluation of antianginal and antiischemic efficacy of nicorandil: results of a multicenter study. J Am Coll Cardiol. 23:1994;267A.
-
(1994)
J Am Coll Cardiol
, vol.23
-
-
Thadani, U.1
Strauss, W.2
Glasser, S.P.3
Frishman, W.4
Burger, A.J.5
Locker, J.6
Mohrland, J.S.7
-
55
-
-
0024395336
-
A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris
-
Camm J.A., Maltz M.B. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris. Am J Cardiol. 63:1989;61J-65J.
-
(1989)
Am J Cardiol
, vol.63
-
-
Camm, J.A.1
Maltz, M.B.2
-
56
-
-
0024995674
-
Comparison of nicorandil and atenolol in stable angina pectoris
-
Hugues L.O., Rose E.L., Lahiri A., Raftery E.B. Comparison of nicorandil and atenolol in stable angina pectoris. Am J Cardiol. 66:1990;679-682.
-
(1990)
Am J Cardiol
, vol.66
, pp. 679-682
-
-
Hugues, L.O.1
Rose, E.L.2
Lahiri, A.3
Raftery, E.B.4
-
57
-
-
0026748339
-
Pharmacological evidence for a role of ATP dependent potassium channels in myocardial stunning
-
Auchampach J.A., Maruyana M., Cavero I., Gross G.J. Pharmacological evidence for a role of ATP dependent potassium channels in myocardial stunning. Circulation. 86:1992;311-319.
-
(1992)
Circulation
, vol.86
, pp. 311-319
-
-
Auchampach, J.A.1
Maruyana, M.2
Cavero, I.3
Gross, G.J.4
-
58
-
-
0027548579
-
ATP channels: An endogenous protective mechanism during repetitive ischemia
-
ATP channels: an endogenous protective mechanism during repetitive ischemia. Am J Physiol. 264:1993;H495-H504.
-
(1993)
Am J Physiol
, vol.264
-
-
Yao, Z.1
Cavero, I.2
Gross, G.J.3
-
59
-
-
0029073627
-
Ischaemic preconditioning: Is it clinically relevant?
-
Verdouw P.D., Gho B.C.G., Dunker D.J. Ischaemic preconditioning: is it clinically relevant? Eur Heart J. 16:1995;1169-1176.
-
(1995)
Eur Heart J
, vol.16
, pp. 1169-1176
-
-
Verdouw, P.D.1
Gho, B.C.G.2
Dunker, D.J.3
-
61
-
-
0029081730
-
Activation of ATP-sensitive potassium channels: A novel pharmacological approach to myocardial protection?
-
Hearse D.J. Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection? Cardiovasc Res. 30:1995;1-17.
-
(1995)
Cardiovasc Res
, vol.30
, pp. 1-17
-
-
Hearse, D.J.1
-
62
-
-
0028182423
-
ATP channel opener Bimakalim on coronary blood low, monophasic action potential duration and infarct size in dogs
-
ATP channel opener Bimakalim on coronary blood low, monophasic action potential duration and infarct size in dogs. Circulation. 89:1994;1769-1775.
-
(1994)
Circulation
, vol.89
, pp. 1769-1775
-
-
Yao, Z.1
Garrett, J.2
Gross, G.J.3
-
63
-
-
0027998778
-
+ channel blocker
-
+ channel blocker. Circulation. 90:1994;700-705.
-
(1994)
Circulation
, vol.90
, pp. 700-705
-
-
Tomai, F.1
Crea, F.2
Gaspardone, A.3
Versaci, F.D.E.4
Paulis, R.5
Penta, D.E.6
Peppo, A.7
Chiariello, L.8
Gioffre, P.A.9
-
64
-
-
0343174033
-
The effect of intracoronary adenosine on preconditioning during PTCA
-
Kerensky R.A., Kutcher M.A., Braden G.A., Applegate R.J., Solis G.A., Little W.C. The effect of intracoronary adenosine on preconditioning during PTCA. Circulation. 88:1993;I-588.
-
(1993)
Circulation
, vol.88
, pp. 588
-
-
Kerensky, R.A.1
Kutcher, M.A.2
Braden, G.A.3
Applegate, R.J.4
Solis, G.A.5
Little, W.C.6
-
66
-
-
85047680900
-
Electrophysiological effects of ATP sensitive potassium channel modulation: Implications for arrhythmogenesis
-
Wilde A.M., Janse M.J. Electrophysiological effects of ATP sensitive potassium channel modulation: implications for arrhythmogenesis. Cardiovasc Res. 28:1994;16-24.
-
(1994)
Cardiovasc Res
, vol.28
, pp. 16-24
-
-
Wilde, A.M.1
Janse, M.J.2
-
67
-
-
85047675589
-
Blockers of ATP sensitive potassium current are of potential benefit in ischaemic heart disease
-
Siegel P. Blockers of ATP sensitive potassium current are of potential benefit in ischaemic heart disease. Cardiovasc Res. 28:1994;31-32.
-
(1994)
Cardiovasc Res
, vol.28
, pp. 31-32
-
-
Siegel, P.1
-
68
-
-
85023412322
-
ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease
-
Cavero I., Premmereur J. ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease. Cardiovasc Res. 28:1994;32-33.
-
(1994)
Cardiovasc Res
, vol.28
, pp. 32-33
-
-
Cavero, I.1
Premmereur, J.2
-
69
-
-
0028126596
-
+ channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts
-
+ channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts. Circulation. 90:1994;2213-2224.
-
(1994)
Circulation
, vol.90
, pp. 2213-2224
-
-
Koumi, S.I.1
Arentzen, C.E.2
Backer, C.L.3
Wasserstrom, A.4
-
70
-
-
0031041032
-
f, in ventricular myocytes from human failing hearts
-
f, in ventricular myocytes from human failing hearts. Circulation. 95:1997;568-571.
-
(1997)
Circulation
, vol.95
, pp. 568-571
-
-
Cerbai, E.1
Pino, R.2
Porciatti, F.3
-
71
-
-
0027944528
-
Sudden cardiac death in heart failure; The role of abnormal repolarization
-
Tomaselli G.F., Beuckelmann D.J., Calgins H.G., Berger R.D., Kessler P.D., Lawrence J.H., Kass D., Feldman A.M., Marban E. Sudden cardiac death in heart failure; The role of abnormal repolarization. Circulation. 90:1994;2534-2539.
-
(1994)
Circulation
, vol.90
, pp. 2534-2539
-
-
Tomaselli, G.F.1
Beuckelmann, D.J.2
Calgins, H.G.3
Berger, R.D.4
Kessler, P.D.5
Lawrence, J.H.6
Kass, D.7
Feldman, A.M.8
Marban, E.9
-
72
-
-
0030012835
-
Missense mutation in the pore region of HERG causes familial long QT syndrome
-
Benson D.W., MacRae C.A., Vesely M.R.et al. Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation. 93:1996;1791-1795.
-
(1996)
Circulation
, vol.93
, pp. 1791-1795
-
-
Benson, D.W.1
MacRae, C.A.2
Vesely, M.R.3
-
73
-
-
0029847602
-
Multiple mechanisms in the long QT syndrome
-
Roden D.M., Lazzara R., Rosen M., Schwartz P.J., Towbin J., Vincent M. Multiple mechanisms in the long QT syndrome. Circulation. 94:1996;1996-2012.
-
(1996)
Circulation
, vol.94
, pp. 1996-2012
-
-
Roden, D.M.1
Lazzara, R.2
Rosen, M.3
Schwartz, P.J.4
Towbin, J.5
Vincent, M.6
-
76
-
-
0029761822
-
HERG, a primary human ventricular target of the non-sedating antihistamine terfenadine
-
Roy M.L., Dumaine R., Brown A.M. HERG, a primary human ventricular target of the non-sedating antihistamine terfenadine. Circulation. 94:1996;817-823.
-
(1996)
Circulation
, vol.94
, pp. 817-823
-
-
Roy, M.L.1
Dumaine, R.2
Brown, A.M.3
-
77
-
-
0000035081
-
Cisapride and torsades de pointes
-
Wolfe S.M., Ahmad S.R. Cisapride and torsades de pointes. Lancet. 345:1995;508.
-
(1995)
Lancet
, vol.345
, pp. 508
-
-
Wolfe, S.M.1
Ahmad, S.R.2
-
78
-
-
0342304497
-
Prolongation of QT interval induced by erythromycin may be explained by an inhibition of the rapid component of the delayed rectifier potassium IKr
-
Daleau P., Turgeon J. Prolongation of QT interval induced by erythromycin may be explained by an inhibition of the rapid component of the delayed rectifier potassium IKr. Circulation. 90:1994;1-248.
-
(1994)
Circulation
, vol.90
, pp. 1-248
-
-
Daleau, P.1
Turgeon, J.2
-
79
-
-
0030468097
-
Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes
-
Antzelevitch C., Sun Z.Q., Zhang Z.Q., Yan G.X. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. J Am Coll Cardiol. 28:1996;1836-1848.
-
(1996)
J Am Coll Cardiol
, vol.28
, pp. 1836-1848
-
-
Antzelevitch, C.1
Sun, Z.Q.2
Zhang, Z.Q.3
Yan, G.X.4
|